Atlas Trials

Neuromuscular Blockade

211 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neuromuscular Blockade

RecordFirmDate
The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery (NCT02580188)Seoul National University Bundang Hospital2015-03-24
Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia (NCT02387021)Institut Kassab d'Orthopédie2015-03-01
Determination of TOF Test Threshold for Obtaining Reliable Pedicle Screw Stimulation Test During Lumbar Spine Surgery (NCT02285829)NYU Langone Health2015-02-11
Bilateral Transversus Abdominis Plane Block Versus Atracurium During Laparoscopic Gynecology Procedures. (NCT03701256)University Tunis El Manar2015-02-01
A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic Anesthesia (NCT02256280)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2015-01-01
Comparing Reversal With Neostigmine and Sugammadex in Paediatric (NCT03137290)Universiti Sains Malaysia2014-12-01
Neurostimulation and Electromyographic Assessment of the TetraGraph (NEAT) In Patients (NEAT-3) (NCT02241304)University of Debrecen2014-07-01
The Effect of Deep Block Versus Moderate Block on the Stress Response After Laparoscopic Gastrectomy (NCT02100280)Seoul National University Bundang Hospital2014-06-29
Qualitative Analysis of Barriers to Consistent Use of Neuromuscular Monitoring in General Anaesthesia (NCT02239965)Herlev Hospital2014-06-01
Sugammadex Provide Better Surgical Condition Compared With Neostigmine in Laryngeal Microsurgery. (NCT02330172)Seoul National University Hospital2014-05-01
Optimizing Surgical Conditions During Gynecologic Laparoscopic Surgery With Deep Neuromuscular Blockade (NCT01933425)Herlev Hospital2013-08-01
A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients (NCT01761552)Hadassah Medical Organization2013-08-01
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine (NCT05066035)Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital2013-05-01
Pilot Study on the Pharmacodynamics of Sugammadex in Morbidly Obese Patients: Reversal of Deep Neuromuscular Blockade (NCT01855217)St. Antonius Hospital2013-04-01
Pharmacokinetic and Pharmacodynamic of Rocuronium (NCT02376595)Pontificia Universidad Catolica de Chile2013-03-01
Frequency of Residual Neuromuscular Blockade in the Pediatric Population (NCT01786863)Nationwide Children's Hospital2013-02-01
Recovery After Laparoscopic Hysterectomy With Deep Neuromuscular Blockade and Low Intra-abdominal Pressure (NCT01722097)Herlev Hospital2012-11-01
Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex (NCT01828385)Universidade Federal do Rio de Janeiro2012-10-01
Minimum Local Anesthetic Dose for Adductor Canal Block (NCT03427385)University Health Network, Toronto2012-09-01
Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery (NCT01613781)Samsung Medical Center2012-06-01
Sugammadex-dosing in Bariatric Patients (NCT01570179)Central Hospital, Nancy, France2012-05-01
Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea (NCT01672606)Malin Jonsson Fagerlund2012-05-01
Clinical Application of "Train of Four" Testing in the Intraoperative Monitoring Setting (NCT01932983)NYU Langone Health2012-04-01
Sugammadex and Smoker's Neuromuscular Block (NCT05313100)Duzce University2012-04-01
Rocuronium Dose Finding Study After Single-shot or Steady-state Propofol Anesthesia (NCT02054468)Technical University of Munich2012-03-01
Comparative Study of Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade in Morbidly Obese Patients (NCT01629394)University of Patras2012-01-01
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (NCT01431326)Daniel Benjamin2011-11-01
Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038) (NCT01422304)Merck Sharp & Dohme LLC2011-10-12
Reversal With Sugammadex From Deep Neuromuscular Blockade Induced by Rocuronium in Children: Randomised Clinical Trial (NCT01809886)Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia2011-10-01
Efficacy and Safety of Sugammadex in Renal Diseased Patients (NCT01785758)Federal University of São Paulo2011-10-01
Popliteal Approach to Sciatic Nerve Block Is Not Inferior to Infragluteal Approach (NCT03410888)University Health Network, Toronto2011-08-01
Sciatic Nerve Block Using the Subgluteal Space Approach: A Comparison With the Infragluteal Approach (NCT01814605)University Health Network, Toronto2011-06-01
Incidence of Incomplete Postoperative Neuromuscular Recovery From Anesthesia (P07535)(Completed) (NCT01181349)Merck Sharp & Dohme LLC2010-07-01
Sugammadex Improves Muscle Function After Standard Neuromuscular Recovery (NCT01101139)Technical University of Munich2010-04-01
Comparison of Sugammadex With Neostigmine as Reversal Agents for Rocuronium at Reappearance of T2 (Study P06101) (NCT01050543)Merck Sharp & Dohme LLC2010-02-01
Efficacy and Safety of 4.0 mg/kg Sugammadex at 1-2 PTC in Chinese and European Subjects (Study 19.4.335)(P05775AM1)(COMPLETED) (NCT00826176)Merck Sharp & Dohme LLC2010-01-01
Comparison of 2.0 mg/kg Sugammadex and Neostigmine at Reappearance of T2 in Chinese and European Subjects (Study 19.4.324)(P05768AM1)(COMPLETED) (NCT00825812)Merck Sharp & Dohme LLC2010-01-01
The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy (NCT01450813)Medtronic - MITG2009-06-01
Neuromuscular Blockade Improves Surgical Conditions (NCT00895778)Technical University of Munich2009-03-01
Rocuronium Plus Sugammadex Versus Succinylcholine Alone in Participants Undergoing Short Surgical Procedures (19.4.319)(P05700 AM2)(COMPLETED) (NCT00751179)Merck Sharp & Dohme LLC2008-11-01
Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767) (NCT00758485)Merck Sharp & Dohme LLC2008-10-01
Dialysis of Sugammadex in Participants With Severe Renal Impairment (Study 19.4.333) (P05773) (NCT00656799)Merck Sharp & Dohme LLC2008-04-01
Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agents (NCT00660413)Rigshospitalet, Denmark2007-12-01
Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698) (NCT00535496)Merck Sharp & Dohme LLC2007-09-01
The Precision and Arm-to-Arm Variation of Mechanomyography and Acceleromyography for Monitoring of Neuromuscular Block (NCT00472121)Rigshospitalet, Denmark2007-05-01
Modification of Posttetanic Count (PTC) for Monitoring Deep Neuromuscular Block II (NCT00390507)Rigshospitalet, Denmark2006-10-01
The Effect of Magnesium Sulphate on the Time Course of Rocuronium Induced Neuromuscular Block (NCT00405977)University Hospital, Geneva2006-05-01
Performance of Acceleromyography With and Without Preload (NCT00226018)Rigshospitalet, Denmark2005-03-01
Efficacy and Safety of Org 25969 Administered After Zemuron® (MK-8616-042) (NCT03519867)Merck Sharp & Dohme LLC2004-08-01
Efficacy, Safety and Pharmacokinetics of Sugammadex (Org 25969; MK-8616) at 3 Different Time Points After 0.6 mg/kg Esmeron® in Male Participants (P05940; MK-8616-020). (NCT03519854)Merck Sharp & Dohme LLC2002-12-01
← Previous Next →

Track Neuromuscular Blockade automatically

Every clearance here is in the API, with alerts when new ones post.